Aclaris Therapeutics Inc
ACRS
Market Cap$158.09M
Close$
$1.82
18.7% upside
Current Fair Value
18.7% upsideUndervalued by 18.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $158.09 Million |
|---|---|
| Enterprise Value | $137.98 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.71 |
| Beta | 0.43 |
| Outstanding Shares | 122,390,303 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.37 |
|---|---|
| PEG | 12.53 |
| Price to Sales | - |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 7.76 |
| Enterprise Value to EBIT | -2.5 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Aclaris Therapeutics Inc
CEO: Neal Walker